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Abstract Plasmodium vivax is a very common human malaria
parasite but it is poorly characterized at the molecular level.
Here, we describe the isolation and characterization of an
antigen coding gene of P. vivax which contains Alu elements.
This gene, called Pv-Alu, is expressed during the erythrocytic
phase of the parasite. The encoded 200 amino acid long
polypeptide is highly hydrophobic, contains transmembrane
domains, and is rich in leucine (19.4%), serine (15.9%), proline
(15.4%) and phenylalanine (15.4%). The 5P-untranslated region
and part of the 3P-end coding region of Pv-Alu show significant
homology to different Alu families. The presence of Alu elements
in the coding region of a parasite antigen gene is significant from
a functional and evolutionary viewpoint.
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1. Introduction
Malaria a¡ects millions of people world-wide. To date, it
remains uncontrolled. A large number of parasite molecules
have been identi¢ed and characterized from the easily culti-
vable human malaria parasite Plasmodium falciparum. These
molecules are now being used in developing vaccine and ther-
apeutic drugs. By contrast, the sister parasite, P. vivax, is
poorly characterized at the molecular level, probably due to
its non-cultivable nature. We have isolated and characterized
several sero-reactive genomic DNA clones of this parasite,
including PV12, in our previous studies [1^4]. Here, we de-
scribe the complete gene sequence of PV12 which contains
Alu elements.
The Alu elements are 250^300-bp repeat sequences, con-
taining two homologous subunits which are derived from
7SL RNA genes and their presence is linked to the evolution
[5^7]. These sequences are generally present in introns or in-
tergenic regions and may be involved in the regulation of gene
expression and gene rearrangement [8,9]. Furthermore, their
retroposition in protein coding regions is a source of protein
variability but sometimes can cause disease [10]. We report
here, probably for the ¢rst time, the presence of Alu elements
in a P. vivax blood stage antigen gene which could be of
signi¢cance from the viewpoint of host^parasite interaction
and parasite evolution.
2. Materials and methods
2.1. Construction and screening of P. vivax genomic library
A genomic library of P. vivax was constructed in lambda EMBL3
vector. Brie£y, the parasite DNA used earlier to construct the lambda
gt11 library [1], was partially digested with Sau3A1 and 10^24-kbp
fragments were puri¢ed by running a sucrose density gradient. These
DNA fragments were ligated to the commercially available dephos-
phorylated BamHI arms of the lambda EMBL3, and then packaged in
vitro (Promega Corporation, Madison, WI, USA).
The library was plated and screened at a density of 10 000^12 000
plaques per 85-mm agar plate. The plaques were transferred to nitro-
cellulose discs and hybridized with the 446-bp insert of the previously
isolated clone, called PV12 [2]. The hybridization was carried out at
42‡C for 16 h using 50% formamide in the bu¡er (5USSC containing
0.1% each of SDS, polyvinylpyrrolidine, Ficoll 800 and BSA plus 200
Wg per ml of denatured salmon sperm DNA). The ¢lters were ¢nally
washed with 0.2USSC containing 0.1% SDS for 1 h at 65‡C and
exposed to X-ray ¢lms.
2.2. Subcloning and nucleotide sequencing
The 12-kbp insert from the positive EMBL3 clone (PV12-ECI) was
cleaved with various enzymes and a 2.1-kbp BamHI fragment, hybrid-
izing with the 446-bp probe of PV12, was subcloned into pGEM7Z
and restriction mapped. Overlapping fragments from this 2.1-kbp
BamHI clone (12B6) were subcloned into pGEM3Z and 7Z vectors
and sequenced by dideoxynucleotide chain termination method [11].
The sequence homology search was carried out by using the FASTA
program and the EMBL data base. Sequence analysis and compar-
isons were performed using PCGENE software (Release 6.01, Intelli-
genetics).
2.3. RNA dot blot assay
The isolation of total and poly A RNA from the P. vivax-infected
erythrocytes and the cDNA synthesis were carried out as described
earlier [12]. The dot hybridization of total RNA from P. vivax and
human PBMCs was carried out by standard protocol [13]. Brie£y, the
RNA was dissolved in 10 Wl water and mixed with 20 Wl of 100%
formamide, 7 Wl of formaldehyde (37%) and 2 Wl of 20USSC. The
mixture was incubated at 68‡C for 15 min, cooled on ice and 2 Wl of
20USSC added. The sample was then blotted onto nitrocellulose
membrane using a SRC-96-D manifold apparatus (Schleicher p
Schuell, Germany). The ¢lter was hybridized with the 446-bp insert
of PV12 under the conditions described in Section 2.1.
2.4. Reverse transcription PCR
The PCR ampli¢cation was carried out by using P. vivax cDNA,
genomic DNA and human DNA. All ampli¢cations were carried out
in a volume of 50 Wl. For cDNA ampli¢cation 50 ng of template and
2 mM MgCl2 was used in the reaction mixture, while 150 ng of
template and 1.5 mM MgCl2 was used for genomic DNA. Other
components of the reaction mixture were the same for both templates
^ 10 mM Tris-HCl (pH 8.8), 50 mM KCl, 0.001% (w/v) of gelatin, 200
WM dNTP, 1 WM of each primer and 2.5 units of Taq DNA polymer-
ase (Stratagene, Heidelberg, Germany). The sequence of primers for
PV12 (12F+12R) and Pv-Alu (AF+12R) is as follows: 12F: 5P-AT-
GATTCAAAAGCCATCTG-3P ; 12R: 5P-CATAGTGAGACTCT-
TG-3P ; AF: 5P-GTCGACTATGTCTCTTTC-3P.
The PCR ampli¢cation was carried out for 35 cycles with a temper-
ature and time pro¢le as follows: denaturation at 95‡C for 1 min,
annealing at 56‡C (12F+12R) or 45‡C (AF+12R) for 1 min, extension
at 73‡C for 1 min. Denaturation at 95‡C before cycling and extension
at 73‡C at the end of the cycle were carried out for 10 min each. The
ampli¢ed products were analyzed on 1.2% agarose gel.
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3. Results
3.1. Cloning and sequence analysis of Pv-Alu gene
Previously, we have described the isolation of several sero-
positive clones by immunological screening of lambda gt11-P.
vivax genomic library with patient’s sera [1]. One of the clones
‘PV12’ showing 79% seropositivity rate among P. vivax-in-
fected individuals [2], was used here to screen the lambda
EMBL3-P. vivax DNA library. Screening of 1.8U105 clones
resulted in the isolation of the positive clone (PV12-ECI). A
total of 1.1-kbp segment from this 12-kbp fragment was se-
quenced which covered the 446 bp of PV12 (Fig. 1). We also
sequenced PV12 to determine the open reading frame (ORF)
by using lambda gt11 primers. The nucleotide and its deduced
amino acid sequences of the complete Pv-Alu gene are shown
in Fig. 1. The 600-bp ORF contains two methionine (ATG)
codons which are situated 96 bp apart. The 5P ATG has a
number of characteristics in consensus with Plasmodium start
codons as described by Saul and Battistutta [14]. The se-
quence 5P to this ATG has a conserved ‘A’ in the 33 position
[15]. Analysis for eukaryotic promoter sequences showed that
this ATG is related to a promoter complex consisting of a GC
box (bases 3338 to 3325), a TATA box (bases 3223 to
3209) and two contiguous cap signal sites (bases 3195 to
3188 and 3187 to 3180). The ORF is not £anked by con-
served sequences for mRNA splice donor or acceptor sites
[16]. The deduced amino acid sequence shows unusually
high contents of leucine (19.4%), phenylalanine (15.4%), pro-
line (15.4%) and serine (15.9%). This 200 amino acid long
polypeptide is highly hydrophobic (Fig. 2). The ¢rst hydro-
phobic region, which could represent a signal peptide, spans
the N-terminal amino acids 1^24 and includes a putative
transmembrane domain extending between residue 2 and 19.
There is a strong putative anchor peptide extending between
residue 1 and 10 in this region. The second hydrophobic re-
gion extends from residue 41 to 139, with two predicted trans-
membrane helices lying between residues 72 to 112 and 122 to
139. The protein ends in a hydrophobic tail extending from
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Fig. 1. Nucleotide and deduced amino acid sequence of the Pv-Alu gene. The beginning and end of the 446-bp nucleotide sequence of PV12 in
gt11 is indicated by bold GATC sequence. The conserved ‘A’ at 33 position and the ¢rst nucleotide of the Pv-Alu ORF (+1) are indicated.
Stars (*) indicate the stop codons at the 5P- and 3P- ends of the ORF. The predicted GC box, TATA box and CAP sites are underlined. The
26-bp sequence containing chi-like element (complementary strand) is overlined. The complete nucleotide sequence of Pv-Alu has been deposited
into the EMBL data base with accession number X92485.
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171 to 200 amino acids. Of the two hydrophilic stretches, the
¢rst extends between residues 22 to 40 and contains the most
probable B-cell epitope between position 35 and 40. The sec-
ond hydrophilic region extends between residue 140 and 160,
where two probable B-cell epitopes are predicted between res-
idues 152 to 157 and 168 to 173. There are two putative
glycosylation sites at residues 162 and 169, a myristylation
site at residue 146 and two phosphorylation sites at 38 and
149 amino acid residues.
The nucleotide and amino acid sequences of Pv-Alu do not
show signi¢cant homology to any of the malarial genes or
proteins in the data base. Surprisingly, the parts of Pv-Alu
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Fig. 2. Hydropathy curve of the Pv-Alu protein. The protein has a hydropathy index of 0.66. The upper half of the ¢gure (positive index) indi-
cates hydrophobicity, whereas the lower half (negative index) indicates hydrophilicity.
Fig. 3. Schematic diagram showing sequence homology between Pv-Alu and other Alu sequences in the databases EMBL and GENBANK.
The hatched box indicates the 600-bp Pv-Alu ORF coding for 200 amino acids, while the stippled area marks the PV12 sequence. The arrow-
heads indicate the position of the primers used for PCR (AF, 12F and 12R). The arrows (above Pv-Alu) indicate the 5P to 3P direction of vari-
ous genes in the database where Alu sequences are present as part of introns. Pv-Alu: P. vivax gene with Alu-element; Alu: Alu consensus se-
quences from Alu-J and Alu-S subfamilies showing varying degree of identity (70^87%) with 3P-end of Pv-Alu; Sb: member of Alu S subfamily
(accession number U14568; 75^213 nucleotides); PV: PV83, a human DNA Alu repeat from multiple source gene (X53549; 105^341 nucleo-
tides); Gb: Alu repeat element in gorilla beta globin gene (X06123; 151^400 nucleotides); Gg: Alu repeat element in gorilla gamma globin
gene (M92295; 72^356 nucleotides) ; Hg: Alu repeat element from human gamma crystallin gene (M19364; 3460^3808 nucleotides); Hm: intron
from Homo sapiens multidrug resistance (mdrI) gene (X78081; 2860^3019 nucleotides); Hb: ¢rst intron from human proteinase 3 gene
(M96838; 3^279 nucleotides); Hs: Homo sapiens SP40, 40A gene (L00974; 6529^6813 nucleotides); T5/18: Alu repeat element from Tre 5 and
Tre 18 sequence of Homo sapiens tre oncogene (X63735; 452^790 nucleotides) and from Tre 5 mRNA (X78262; 6670^7000 nucleotides); VD:
human vitamin D binding protein gene (L10641; 32 842^33 160 nucleotides). The amino acid identities (placed below Pv-Alu) are from deduced
amino acid sequences from various Alu subfamilies stored in the database as ‘warning entries’. The crosses (x) and breaks (//) indicate stop co-
dons and change in translational frames, respectively. C: database warning entry showing a six-frame conceptual translation of one of six (A^
F) Alu deduced amino acid classes (P23961; 405^593 amino acids); J: Alu-J subfamily (P39188; 397^486 amino acids); Alu-S subfamily mem-
bers Sb (P39189; 387^469 amino acids), Sb1 (P39190; 387^469 amino acids), Sc (P39192; 393^481 amino acids), Sp (P39193; 498^588 amino
acids), Sq (P39194; 418^587 amino acids); Sx (P39195; 389^479 amino acids). The database accession numbers for various genes/protein se-
quences and their region of homology with Pv-Alu are given in brackets.
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show a signi¢cant nucleotide and amino acid sequence homol-
ogy with various Alu families (see Fig. 3). It seems that there
are two Alu elements in the gene; one element is located at the
5P-untranslated region while the other is at the 3P-end of the
ORF.
3.2. Pv-Alu gene is transcribed and translated during the
erythrocytic phase of the parasite
The mRNA isolated from the blood stages of P. vivax was
subjected to reverse transcription PCR using PV12 (12F+12R)
and Pv-Alu (AF+12R) speci¢c primers (the position of the
primers is indicated in Fig. 3). The ampli¢cation of 430-bp
(PV12) and 530-bp (Pv-Alu) size products in RT-PCR indi-
cated that the gene is transcribed during the erythrocytic
phase of the parasite’s life cycle. The sizes of PCR products
were the same for cDNA and genomic DNA templates
(Fig. 4). There was no PCR ampli¢cation from human
DNA, indicating the speci¢city of primers to P. vivax sequen-
ces. Similar results of gene transcription were obtained when
total RNA from blood stages of the parasite was dot blotted
onto nitrocellulose paper and hybridized with PV12 (Fig. 4).
The translation of this RNA has already been con¢rmed
since the expressed PV12 recombinant antigen is being recog-
nized by the vivax patient’s antibodies during gt11 library
screening [1]. This was further con¢rmed by the human hu-
moral immune response results where 79% of vivax-infected
patients were seropositive against this recombinant antigen
[2].
4. Discussion
We have cloned and sequenced the gene encoding a blood
stage antigen of P. vivax called Pv-Alu. The gene shows se-
quence homology, in parts, to Alu families yet it has certain
unique characteristic features such as: (a) the 600-bp ORF is
much larger than any Alu sequence; (b) no mRNA splice site
in the coding as well as £anking regions of Pv-Alu. The ab-
sence of an intron is also evident from the PCR results where
same sized products were obtained from the P. vivax genomic
and cDNA. (c) The typical organization of the Alu element ^
two homologous subunits joined by an adenine-rich linker
and a polyadenylated tail ^ is present in the sequence, albeit
with some di¡erences.
Pv-Alu could play an important role in generating antigenic
diversity to evade the host immune system, which is typical of
the malarial parasite. This is because the Alu elements are
involved in recombination and gene rearrangement, and in
gene expression [8^10,17]. The presence of a 26-bp sequence
(5P-CCTGTAATCCCAGCACTTTGGGAGGC-3P) at the 3P-
end of the Pv-Alu ORF, in the complementary strand, is also
of signi¢cance (Fig. 1). This sequence, which has a prokary-
otic chi-like motif (CCAGC) embedded in it, is well conserved
among Alu-sequences and has been found to play a role in
homologous and non-homologous recombination in human
[17]. This 26-bp sequence also has a CTT signature site for
topoisomerase I action, and topoisomerase I and II mediated
non-homologous recombination [17]. The subsequences CTT
and CCAGC are also present at many places in Pv-Alu, par-
ticularly at the 5P-end of the ORF. The presence of CTTT
(tetramer) repeats in the 5P region of the ORF indicates that
the parasite can evolve yet another mechanism of producing
divergent antigenic molecules by slipped strand mispairing,
resulting in frame shift mutations. This, in e¡ect, would gen-
erate di¡erent Pv-Alu protein molecules after each erythro-
cytic cycle in the same infected individual. This is similar to
the mechanism that has been reported in the opa gene of
Neisseria [18].
The mechanisms of acquisition of Alu sequences by parasite
are not clear at this stage. However, the possibility of transfer
of such genetic material between host and parasite via viral
co-infection cannot be ruled out. This is because viruses have
the ability to acquire host genetic material. Although no virus
in malaria parasite has been reported as yet, unlike other
protozoan parasites such as Entamoeba, Giardia, Leishmania,
Trichomonas, Babesia and Eimeria [19], such a possibility can-
not be ruled out.
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Fig. 4. Transcription and speci¢city of the Pv-Alu gene. A: Dot-blot hybridization of total RNA (5 Wg each) from erythrocytic stage of P. vi-
vax (Pv) and human PBMC (H) using PV12 446-bp insert as probe. B: Agarose gel electrophoresis of PCR ampli¢ed products. The primers
speci¢c for PV12 (12F+12R, lanes 1^3) and Pv-Alu (AF+12R; lanes 4^6) were used for the P. vivax genomic DNA (lanes 1 and 4), cDNA
(lanes 3 and 5) and human DNA (lanes 2 and 6). The marker lane (M) contains a 50^2000-bp DNA ladder. The 430-bp (with 12F+12R) and
530-bp (with AF+12R) ampli¢ed products are indicated by arrowheads.
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5. Conclusion
In conclusion, the P. vivax malaria parasite contains Alu-
like sequences in a probable integral membrane protein gene
named Pv-Alu. This gene is expressed during the parasite’s
erythrocytic phase and is antigenic in the human host. The
structural features of the Pv-Alu gene indicate its involvement
in generating antigenic diversity to evade the host immune
system. The Pv-Alu could also play a signi¢cant role in the
parasite’s survival and further evolution through controlled
gene expression and rearrangement.
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